GLP-1s Are At the Forefront, but Other Obesity Treatments Exist
Pharmacy Times
NOVEMBER 7, 2024
In addition to GLP-1s, dual GLP-1 and GIP agonists, intestinal lipase inhibitors, sympathomimetics, and other agents can help patients lose weight.
Thu.Nov 07, 2024
149 
These 6 companies are using AI to streamline clinical trials for pharma
STAT
NOVEMBER 7, 2024
In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Implementation of Supply-Related Restrictive Measures Reduces IVIG Use
Pharmacy Times
NOVEMBER 7, 2024
Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.
Quest Diagnostics expands network partnership with Anthem plans
Fierce Healthcare
NOVEMBER 7, 2024
Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it easier for patients to access in-network laboratory services. | Quest Diagnostics and Elevance Health are broadening their partnership into four more states, with the goal of making it easier for patients to access in-network laboratory services.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Risk of Developing Eosinophilic Esophagitis Is Higher in Pediatric Patients With Atopic Conditions
Pharmacy Times
NOVEMBER 7, 2024
Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.
General Catalyst's HATCo moves forward on $485M Summa Health deal
Fierce Healthcare
NOVEMBER 7, 2024
Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday. | Venture capital firm General Catalyst's Health Assurance Transformation Corporation signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Sarepta pulls plug on Duchenne exon-skipping drug
pharmaphorum
NOVEMBER 7, 2024
Sarepta has halted development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy therapy Exondys 51.
FDA Proposes Removal of OTC Oral Phenylephrine From Cough/Cold Products
Pharmacy Times
NOVEMBER 7, 2024
Evidence shows that the agent is not an effective nasal decongestant.
Gastrointestinal Stromal Tumors Increased in Past 20 Years
Drug Topics
NOVEMBER 7, 2024
Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.
More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce
Fierce Pharma
NOVEMBER 7, 2024
After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring. | After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring, cutting the autoimmune disease biotech's workforce for a second time in less than a year.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Q&A: Pharmacists Champion Nonopioid Pain Management Strategies
Drug Topics
NOVEMBER 7, 2024
Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.
Webinar recap: Boosting recruitment and retention with SDOH data
pharmaphorum
NOVEMBER 7, 2024
Discover the key takeaways from a webinar focused on boosting recruitment and retention through Social Determinants of Health (SDOH) data. Learn how incorporating SDOH data can enhance your recruitment and retention strategies.
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Fierce Pharma
NOVEMBER 7, 2024
Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its bread-and-butter antirival franchise with an eye on the potential of its long-acting | Gilead's CAR-T therapies Yescarta and Tecartus have stayed relatively flat all year with its Yescarta facing a 1% decline over the third quarter due to competition.
Avid Bioservices to go private in $1.1bn private equity deal
pharmaphorum
NOVEMBER 7, 2024
Nasdaq-listed CDMO Avid Bioservices has agreed a $1.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Lerodalcibep Delivers Significant LDL-C Reduction for High-Risk Cardiovascular Patients
Pharmacy Times
NOVEMBER 7, 2024
Lerodalcibep is a novel, third-generation, anti-PCSK9 therapy small binding protein.
Blueprint's mastocytosis drug Ayvakit cleared for NHS use
pharmaphorum
NOVEMBER 7, 2024
NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis
EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients
Pharmaceutical Technology
NOVEMBER 7, 2024
The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.
Researchers Highlight Need for Increased RSV Vaccination
Pharmacy Times
NOVEMBER 7, 2024
RSV vaccines were 80% effective in preventing hospitalization, ICU admission, and death among adults aged 60 years and older.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Minister for Science champions partnerships with private clinical sector in UK
Pharmaceutical Technology
NOVEMBER 7, 2024
Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.
Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales
Fierce Pharma
NOVEMBER 7, 2024
An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the gene therapy. | An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy Elevidys has sparked a new surge in sales. The gene therapy's $181 million sales in the third quarter beat analysts' expectations as it made a 48% sequential leap.
Aditum Bio and Leads Biolabs Form New Company, Oblenio Bio, for Developing a Therapeutic Antibody to Treat Autoimmune Disorders
BioPharm
NOVEMBER 7, 2024
Under an agreement, Leads Biolabs has granted the new company, Oblenio Bio, an exclusive option to license LBL-051, a tri-specific T-cell engager antibody.
DBV Technologies’ stock slides as financial woes worsens
Pharmaceutical Technology
NOVEMBER 7, 2024
The company reported that it does not have sufficient cash reserves to operate for the next 12 months, can only fund operations into Q1 2025.
Metrics for the UK’s VPAG: A work in progress
pharmaphorum
NOVEMBER 7, 2024
Discover the latest metrics and updates on the UK's VPAG (Voluntary scheme for branded medicines Pricing, Access and Growth) from NICE (National Institute for Health and Care Excellence). Stay informed on this work in progress.
Addressing Racial Disparities in Opioid Prescriptions: The Role of Pharmacists in Achieving Equity
Pharmacy Times
NOVEMBER 7, 2024
Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Fierce Pharma
NOVEMBER 7, 2024
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. | Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. But the Massachusetts biotech's RSV shot fell way short of expectations.
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Outsourcing Pharma
NOVEMBER 7, 2024
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
CerpassRx, Waltz Health team up to bring down specialty pharmacy costs
Fierce Healthcare
NOVEMBER 7, 2024
CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending. | CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending.
Q&A: Key Things Pharmacists Need to Know About Insulin Icodec
Drug Topics
NOVEMBER 7, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.
CHAI members hash out remaining questions about AI assurance labs
Fierce Healthcare
NOVEMBER 7, 2024
At the Coalition for Health AI’s Global Summit in Las Vegas, CHAI members gathered to tease out some of the most basic questions about their proposed national network of AI assurance labs | At the CHAI Global Summit in Las Vegas in October, CHAI members openly debated about who would use the assurance labs and who would pay for model validation, among other fundamental questions.
Senhwa Biosciences starts trial of silmitasertib in children with difficult to treat cancers
Outsourcing Pharma
NOVEMBER 7, 2024
The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults with relapsed or treatment resistant tumors.
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
PharmaVoice
NOVEMBER 7, 2024
Dealmaking this year has been largely muted, but M&A trends are pointing to the areas where pharma is placing the most emphasis.
NeueHealth shows off ‘strongest’ earnings performance but profitability lags
Fierce Healthcare
NOVEMBER 7, 2024
NeueHealth CEO Mike Mikan began the company’s extremely quick third quarter earnings call highlighting the “strongest financial performance to date,” seemingly boosting its stock Oct. 7. | NeueHealth posted another quarterly net loss as the company tries to dig itself out of a huge hole.
Healthcare Email Marketing Strategies: A Guide for Pharma Executives
Pharma Marketing Network
NOVEMBER 7, 2024
In today’s digital world, healthcare email marketing is more than just sending out newsletters. It’s a strategic tool that, when done right, can boost engagement, nurture relationships with healthcare professionals (HCPs), and increase brand awareness. But how can pharma companies truly maximize the potential of email marketing? Let’s dive in and explore some proven strategies.
Let's personalize your content